Búsqueda bibliogáfica / Covid-19

Articulos sobre Covid19 relacionados a Hematología

Actualización al:

 

Articulos sobre Covid19 relacionados a Hematología PubMed últmos 500 artículos. Palabra de búsqueda: Covid19

• Acute leukemia in the time of COVID-19
• A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19
• Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients
• Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
• Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19
• American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Q1 Cell Transplantation and Cellular Therapy Patients in the United StatesX X
• A rapid fatal evolution of Coronavirus Disease-19 (COVID-19) in an advanced lung cancer patient with a long time response to nivolumab
• Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19
• Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic
• Being a doctor will never be the same after the COVID-19 pandemic
• Blood transfusion during the COVID-19 outbreak
• Blood transfusion strategies and ECMO during the COVID-19 pandemic
• Blood transfusion strategies and ECMO during the COVID-19 pandemic- autor´s reply
• Blood and blood product use during COVID-19 Infection
• BTK inhibitors in cancer patients with COVID19: “The winner will be the one who controls that chaos” (Napoleon Bonaparte)
• Cancer care in the time of COVID-19
• CAR T Cell Therapy During the COVID-19 Pandemic
• Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective fromthe International Forumfor Optimizing Care of Older Adults with Myeloma
• Challenges of Convalescent Plasma Therapy on COVID-19
• Changes in Blood Coagulation in Patients with Severe Coronavirus Disease
• Clinical findings in a patient with hemophilia A affected by COVID-19
• Clinical study of mesenchymal stem cell treating acute respiratory distress syndrome induced by epidemic Influenza A (H7N9) infection, a hint for COVID-19 treatment
• Clinical trials and Haemophilia during the COVID-19’ pandemic: Madrid’s Experience
• Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past
• Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
• Coagulopathy of COVID-19 and antiphospholipid antibodies
• Convalescent plasma: A possible treatment of COVID-19 in India
• Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit
  to both donors and recipients alike
• Convalescent plasma in Covid-19: Possible mechanisms of action
• Convalescent plasma transfusion for the treatment of COVID-19: Systematic review
• COVID19 and acute lymphoblastic leukemias of children and adolescents: first recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE)
• COVID19 and acute coagulopathy in pregnancy
• COVID-19 and cancer: what we know so far
• COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET)
• COVID-19 and the clinical hematology laboratory
• COVID-19 and experiences of moral injury in frontline key workers
• COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
• COVID-19 exacerbating inequalities in the US
• COVID-19 Coagulopathy in Caucasian patients
• COVID-19 convalescent plasma
• COVID-19 convalescent plasma transfusion
• Covid-19: FDA approves use of convalescent plasma to treat critically ill patients
• COVID-19: global consequences for oncology
• COVID-19 in Latin America. Several problems undermine the preparedness of countries in Latin America to face the spread
  of COVID-19. Talha Burki reports.
• COVID-19 in persons with haematological cancers
• COVID-19 in Pregnancy: Consider Thromboembolic Disorders and Thromboprophylaxis
• COVID-19 Infection in Cancer Patients: Early Observations and Unanswered Questions
• Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia
• Covid-19: Don’t forget the impact on US family physicians
• Covid-19: Use radiotherapy only if “unavoidable,” says NICE
• COVID 19 in a patient with pre existing acute lymphoblastic leukemia
• COVID-19 in post-transplantation patients- report of two cases
• Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients?
• COVID-19: should we continue to cryopreserve sperm during the pandemic?
• Coronavirus Disease 2019: Coronaviruses and Blood Safety
• Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19
• Correspondence on: Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
• Cost-effectiveness of rivaroxaban plus aspirin (dual pathway inhibition) for prevention of ischaemic events in patients with cardiovascular disease: on top optimisation of secondary prevention medication in the context of COVID-19 pandemia
• Current Status of Cell-Based Therapies for Respiratory Virus Infections: Applicability to COVID-19
• Critically Ill COVID-19 Infected Patients Exhibit Increased Clot Waveform Analysis Parameters Consistent with Hypercoagulability
• D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19
• Deep impact of COVID-19 in the healthcare of LatinAmerica: the case of Brazil
• Deployment of convalescent plasma for the prevention and treatment of COVID-19
• DIC in COVID-19: Implications for Prognosis and Treatment?
• Disseminated intravascular coagulation in patients with 2019- nCoV pneumonia
• Do checkpoint inhibitors compromise the cancer patients’ immunity and increase the vulnerability to COVID-19 infection?
• DOACs and ‘newer’ haemophilia therapies in COVID-19
• Doctors’ wellbeing: self-care during the covid-19 pandemic
• Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?
• Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in COVID-19 Patients
• Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy In Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use
• Expert recommendations on blood purification treatment protocol for patients with severe COVID-19
• From Hematologist’s desk: The effect of COVID-19 on the blood system
• Graft cryopreservation does not impact overall survival allogeneic hematopoietic cell transplantation using post-transplant cyclophosphamide for GVHD prophylaxis
• Hematological findings and complications of COVID-19
• High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients Withv Coronavirus Disease 2019
• High incidence of venous thromboembolic events in anticoagulated severe COVID- 19 patients
• How to manage lymphoid malignancies duringnovel 2019 coronavirus (CoVid-19) outbreak: aBrazilian task force recommendation
• Hypercoagulability of COVID-19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis
• Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge
• Hyperinflammation and Derangement of Renin-Angiotensin-Aldosterone System in COVID-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis
• Incidence of thrombotic complications in critically ill ICU patients with COVID-19
• Immune Thrombocytopenic Purpura in a Patient with Covid-19
• Impact of the COVID-19 pandemic on therapeutic choices in Thrombosis-Hemostasis
• Is There a Role for Tissue Plasminogen Activator (tPA) as a Novel Treatment for Refractory COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)?
• Leukoerythroblastic reaction in a patient with COVID-19 infection
• Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati
• Lupus anticoagulant is frequent in patients with Covid-19
• Managing mental health challenges faced by healthcare workers during covid-19 pandemic
• Management of CLL Patients Early in the COVID-19 Pandemic: An International Survey of CLL Experts
• Management of COVID-19 Related Paediatric Blood Samples in a Clinical Haematology Laboratory
• Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines Maarten Vermeer
• Mechanism of thrombocytopenia in COVID-19 patients
• Mediastinal lymphadenopathy in patients with severe COVID-19
• Mesenchymal stem cells and management of COVID-19 pneumonia
• Mesenchymal Stem Cell Therapy for COVID-19: Present or Future
• Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019
• Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia
• Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use
• Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries
• Morphological anomalies of circulating blood cells in COVID-19
• Multiple Myeloma in the Time of COVID-19
• Outcome of a patient with refractory Hodgkin’s Lymphoma on pembrolizumab, infected with SARS-CoV-2
• Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19
• Personal Safety during the COVID-19 Pandemic: Realities and Perspectives of HealthcareWorkers in Latin America
• Pivotal Role of Convalescent Plasma in Managing Emerging Infectious Diseases
• Points to consider in the preparation and transfusion of COVID-19 convalescent plasma
• Post-donation COVID-19 identification in blood donors
• Potential of Heparin and Nafamostat Combination Therapy for COVID-19
• Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines
• Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High- Dose Heparin for Thromboprophylaxis Justified?
• Rapid Response: Medical students’ perspective on the need for practical solutions when managing mental health throughout a pandemic and beyond
• Rare anaemias, sickle-cell disease and COVID-19
• Reactive lymphocytes in patients with Covid-19
• RE: ISTH interim guidance to recognition and management of coagulopathy in COVID-19
• Reply to "Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy"
• Response to the letter (JTH-2020-00398)
• Response letter to Eosinophil count in severe coronavirus disease 2019 (COVID-19)
• Rewriting the rules for care of MDS and AML patients in the time of COVID-19
• Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis
• SARS-CoV-2: A new aetiology for atypical lymphocytes
• Severe COVID-19 syndrome and direct oral anticoagulant
• Should we stop aspirin prophylaxis in pregnant women when diagnosed with COVID-19?
• Suggestions for thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19
• Successful treatment of plasma exchange followed by intravenous immunogloblin in a critically ill patient with 2019 novel coronavirus infection
• Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients
• The Active Role of a Blood Center in Outpacing the Transfusion Transmission of COVID-19
• The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients
• The convalescent sera option for containing COVID-19
• The CoV-2 outbreak: how hematologists could help to fight Covid-19
• The Essential Role of Patient Blood Management in a Pandemic: A Call for Action
• The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage
• The COVID-19 Pandemic: New Global Challenges for the Hemophilia Community
• The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis
• The old but new: Can unfractioned heparin and low molecular weight heparins inhibit proteolytic activation and cellular internalization of SARSCoV2 by inhibition of host cell proteases?
• THE PROCOAGULANT PATTERN OF PATIENTS WITH COVID-19 ACUTE RESPIRATORY DISTRESS SYNDROME
• Thrombotic complications in critically ill patients with COVID 19
• Thromboembolic risk and anticoagulant therapy in COVID-19 patients: Emerging evidence and call for action
• Thromboinflammation and the hypercoagulability of COVID-19
• Thrombocytopenia and Its Association with Mortality in Patients with COVID-19
• Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series.
• Traditional and Virtual Congress Meetings During the COVID-19 Pandemic and the Post-COVID-19 Era: Is it Time to Change the Paradigm?
• Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia
• Treatment with convalescent plasma for COVID-19 patients in Wuhan, China
• Treatment of 5 Critically Ill Patients WithCOVID-19 With Convalescent Plasma
• Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection
• Type and dose of heparin in COVID-19
• United States Cutaneous Lymphoma Consortium Recommendations for Treatment of Cutaneous Lymphomas During the COVID-19 Pandemic
• Understanding and Addressing Sources of Anxiety Among Health Care Professionals During the COVID-19 Pandemic
• Uncertainties on the prognostic value of D-dimers in COVID-19 patients.
• Variation in Ultrasound Diagnostic Thresholds for Carotid Stenosis in the United States
• Venous thromboembolism in COVID-19 patients
• What do monitoring platelet counts in COVID-19 teach us?